vs
Cinemark Holdings, Inc.（CNK）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Cinemark Holdings, Inc.的季度营收约是Royalty Pharma plc的1.2倍（$776.3M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 4.4%，领先30.0%），Royalty Pharma plc同比增速更快（4.8% vs -4.7%），过去两年Cinemark Holdings, Inc.的营收复合增速更高（15.8% vs 4.6%）
Cinemark Holdings, Inc.是1977年成立的美国连锁影院品牌，总部位于得克萨斯州普莱诺，业务覆盖美洲多地。截至2025年3月，其在美国及拉美地区共运营497家影院、5653块银幕，同时是巴西最大的连锁影院，当地市场份额达30%。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CNK vs RPRX — 直观对比
营收规模更大
CNK
是对方的1.2倍
$622.0M
营收增速更快
RPRX
高出9.4%
-4.7%
净利率更高
RPRX
高出30.0%
4.4%
两年增速更快
CNK
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $776.3M | $622.0M |
| 净利润 | $34.1M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | — | 62.4% |
| 净利率 | 4.4% | 34.4% |
| 营收同比 | -4.7% | 4.8% |
| 净利润同比 | -33.5% | 2.9% |
| 每股收益（稀释后） | $0.33 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNKRPRX
| Q4 25 | $776.3M | $622.0M | ||
| Q3 25 | $857.5M | $609.3M | ||
| Q2 25 | $940.5M | $578.7M | ||
| Q1 25 | $540.7M | $568.2M | ||
| Q4 24 | $814.3M | $593.6M | ||
| Q3 24 | $921.8M | $564.7M | ||
| Q2 24 | $734.2M | $537.3M | ||
| Q1 24 | $579.2M | $568.0M |
净利润CNKRPRX
| Q4 25 | $34.1M | $214.2M | ||
| Q3 25 | $49.5M | $288.2M | ||
| Q2 25 | $93.5M | $30.2M | ||
| Q1 25 | $-38.9M | $238.3M | ||
| Q4 24 | $51.3M | $208.2M | ||
| Q3 24 | $187.8M | $544.0M | ||
| Q2 24 | $45.8M | $102.0M | ||
| Q1 24 | $24.8M | $4.8M |
营业利润率CNKRPRX
| Q4 25 | — | 62.4% | ||
| Q3 25 | — | 70.1% | ||
| Q2 25 | — | 36.3% | ||
| Q1 25 | — | 94.0% | ||
| Q4 24 | — | 60.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 50.2% | ||
| Q1 24 | — | -13.0% |
净利率CNKRPRX
| Q4 25 | 4.4% | 34.4% | ||
| Q3 25 | 5.8% | 47.3% | ||
| Q2 25 | 9.9% | 5.2% | ||
| Q1 25 | -7.2% | 41.9% | ||
| Q4 24 | 6.3% | 35.1% | ||
| Q3 24 | 20.4% | 96.3% | ||
| Q2 24 | 6.2% | 19.0% | ||
| Q1 24 | 4.3% | 0.8% |
每股收益（稀释后）CNKRPRX
| Q4 25 | $0.33 | $0.49 | ||
| Q3 25 | $0.40 | $0.67 | ||
| Q2 25 | $0.63 | $0.07 | ||
| Q1 25 | $-0.32 | $0.55 | ||
| Q4 24 | $0.36 | $0.46 | ||
| Q3 24 | $1.19 | $1.21 | ||
| Q2 24 | $0.32 | $0.23 | ||
| Q1 24 | $0.19 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | — | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CNKRPRX
| Q4 25 | — | $618.7M | ||
| Q3 25 | — | $938.9M | ||
| Q2 25 | — | $631.9M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $929.0M | ||
| Q3 24 | — | $950.1M | ||
| Q2 24 | — | $1.8B | ||
| Q1 24 | — | $843.0M |
总债务CNKRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益CNKRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | — | $9.6B | ||
| Q2 25 | — | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产CNKRPRX
| Q4 25 | — | $19.6B | ||
| Q3 25 | — | $19.3B | ||
| Q2 25 | — | $18.3B | ||
| Q1 25 | — | $17.6B | ||
| Q4 24 | — | $18.2B | ||
| Q3 24 | — | $18.0B | ||
| Q2 24 | — | $17.7B | ||
| Q1 24 | — | $16.1B |
负债/权益比CNKRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CNKRPRX
| Q4 25 | — | $827.1M | ||
| Q3 25 | — | $702.6M | ||
| Q2 25 | — | $364.0M | ||
| Q1 25 | — | $596.1M | ||
| Q4 24 | — | $742.5M | ||
| Q3 24 | — | $703.6M | ||
| Q2 24 | — | $658.2M | ||
| Q1 24 | — | $664.6M |
现金转化率CNKRPRX
| Q4 25 | — | 3.86× | ||
| Q3 25 | — | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | — | 3.57× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNK
| Admissions Revenue | $383.8M | 49% |
| Concessions | $302.4M | 39% |
| Other Revenue | $37.5M | 5% |
| Transferred Over Time | $28.2M | 4% |
| Screen Advertising Screen Rental And Promotional Revenues | $24.4M | 3% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
